Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,920 | N/A | N/A | -1,192 | -4,159 |
| Depreciation Amortization | 190 | N/A | N/A | 53 | 230 |
| Other Working Capital | N/A | N/A | N/A | -27 | -282 |
| Other Operating Activity | 370 | 0 | 0 | 16 | 80 |
| Operating Cash Flow | $-4,360 | $N/A | $N/A | $-1,150 | $-4,131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -4 | -105 |
| Other Investing Activity | -40 | 0 | 0 | 1 | 3,833 |
| Investing Cash Flow | $-40 | $N/A | $N/A | $-3 | $3,728 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 7,890 | 0 | 0 | -2 | 4,344 |
| Financing Cash Flow | $7,890 | $N/A | $N/A | $-2 | $4,344 |
| Beginning Cash Position | 4,090 | N/A | N/A | 4,091 | 150 |
| End Cash Position | 7,560 | N/A | N/A | 2,936 | 4,092 |
| Net Cash Flow | $3,470 | $N/A | $N/A | $-1,155 | $3,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,360 | N/A | N/A | -1,150 | -4,131 |
| Free Cash Flow | -4,360 | 0 | 0 | -1,150 | -4,131 |